- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.65 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x U86: 3-[4-[[2,4-bis(azanyl)-6-ethyl-pyrimidin-5-yl]methyl]phenyl]benzoic acid(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.2: 30 residues within 4Å:- Chain A: C.15, A.16, L.40, G.41, N.42, G.44, V.45, L.46, W.48, G.105, R.106, T.107, N.108, L.127, S.128, R.129, T.130, N.144, K.145, V.146, L.164, G.165, G.166, S.167, V.168, V.169, Y.170, E.172, V.195
- Ligands: U86.1
23 PLIP interactions:23 interactions with chain A- Hydrophobic interactions: A:L.40, A:Y.170
- Hydrogen bonds: A:A.16, A:L.40, A:N.42, A:G.44, A:G.105, A:R.106, A:T.107, A:T.107, A:N.108, A:S.128, A:R.129, A:T.130, A:G.165, A:G.166, A:S.167, A:V.168, A:V.169, A:E.172
- Water bridges: A:S.111
- Salt bridges: A:R.106
- pi-Cation interactions: A:R.129
NDP.4: 29 residues within 4Å:- Chain B: C.15, A.16, L.40, G.41, N.42, G.44, V.45, L.46, W.48, G.105, R.106, T.107, N.108, L.127, S.128, R.129, T.130, N.144, K.145, V.146, L.164, G.166, S.167, V.168, V.169, Y.170, E.172, V.195
- Ligands: U86.5
21 PLIP interactions:21 interactions with chain B- Hydrophobic interactions: B:L.40, B:Y.170
- Hydrogen bonds: B:A.16, B:L.40, B:G.44, B:G.44, B:R.106, B:T.107, B:N.108, B:R.129, B:T.130, B:G.166, B:S.167, B:V.168, B:V.169, B:Y.170, B:E.172
- Water bridges: B:N.42
- Salt bridges: B:R.106, B:R.129
- pi-Cation interactions: B:R.129
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
UMP.3: 14 residues within 4Å:- Chain A: R.345, C.490, H.491, Q.509, R.510, S.511, C.512, D.513, G.517, N.521, H.551, Y.553
- Chain B: R.470, R.471
12 PLIP interactions:2 interactions with chain B, 10 interactions with chain A- Salt bridges: B:R.470, B:R.471, A:R.345, A:R.510
- Hydrophobic interactions: A:D.513
- Hydrogen bonds: A:Q.509, A:S.511, A:S.511, A:D.513, A:N.521, A:N.521, A:H.551
UMP.6: 14 residues within 4Å:- Chain A: R.470, R.471
- Chain B: R.345, C.490, H.491, Q.509, R.510, S.511, C.512, D.513, G.517, N.521, H.551, Y.553
14 PLIP interactions:3 interactions with chain A, 11 interactions with chain B- Water bridges: A:R.470, B:R.345
- Salt bridges: A:R.470, A:R.471, B:R.345, B:R.510
- Hydrophobic interactions: B:D.513
- Hydrogen bonds: B:Q.509, B:S.511, B:D.513, B:N.521, B:N.521, B:H.551, B:Y.553
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hoarau, M. et al., Discovery of rigid biphenyl Plasmodium falciparum DHFR inhibitors using a fragment linking strategy. Rsc Med Chem (2023)
- Release Date
- 2023-08-23
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.65 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x U86: 3-[4-[[2,4-bis(azanyl)-6-ethyl-pyrimidin-5-yl]methyl]phenyl]benzoic acid(Non-covalent)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hoarau, M. et al., Discovery of rigid biphenyl Plasmodium falciparum DHFR inhibitors using a fragment linking strategy. Rsc Med Chem (2023)
- Release Date
- 2023-08-23
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B